Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alyssa R Golden

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Vaccine|April 17, 2016
Invasive Streptococcus pneumoniae in Canada, 2011-2014: Characterization of new candidate 15-valent pneumococcal conjugate vaccine serotypes 22F and 33FAlyssa R Golden, Heather J Adam, George G Zhanel, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|December 15, 2025
Invasive pneumococcal disease caused by vaccine serotype 9V in previously immunized adultsMeagan Deviaene, Alyssa R Golden, Terence Wuerz, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 23, 2026
Meagan Deviaene, Alyssa R Golden, Terence Wuerz, et al.
Epidemiology and Infection|December 23, 2024
Group A streptococcal infections in Alberta, Canada 2018-2023Gregory J Tyrrell, Matthew Croxen, Emily McCullough, et al.
JAMA Network Open|April 9, 2026
Invasive Pneumococcal Disease Epidemiology and Conjugate Vaccines in Canada, 2000-2019Bernice Ramos, Nirma Khatri Vadlamudi, Alyssa R Golden, et al.
Diagnostic Microbiology and Infectious Disease|February 22, 2020
In Vitro Activity of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacilli Isolated from Patients in Canadian Intensive Care UnitsAlyssa R Golden, Heather J Adam, Melanie Baxter, et al.
The Journal of Antimicrobial Chemotherapy|August 28, 2025
Comparison of antimicrobial resistance and serotype patterns in Streptococcus pneumoniae from blood cultures and respiratory specimens in Canadian hospitals from the CANWARD study (2007-23)Heather J Adam, Alyssa R Golden, Irene Martin, et al.
The Journal of Antimicrobial Chemotherapy|August 2, 2024
Phenotypic and molecular characterization of Streptococcus pneumoniae serotype 3 isolates from blood and respiratory samples in Canada: CANWARD 2007-21John J Schellenberg, Heather J Adam, Melanie R Baxter, et al.
Vaccine|September 27, 2023
Clonal diversity of Streptococcus pneumoniae serotype 19A collected from children < 5 years old in Québec, Canada, 2016-2021Alyssa R Golden, Brigitte Lefebvre, Geneviève Deceuninck, et al.
Diagnostic Microbiology and Infectious Disease|June 30, 2021
Invasive pneumococcal disease caused by serotypes 22F and 33F in Canada: the SAVE study 2011-2018Alyssa R Golden, Thomas Fear, Melanie Baxter, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Vaccine|April 17, 2016
Invasive Streptococcus pneumoniae in Canada, 2011-2014: Characterization of new candidate 15-valent pneumococcal conjugate vaccine serotypes 22F and 33FAlyssa R Golden, Heather J Adam, George G Zhanel, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|December 15, 2025
Invasive pneumococcal disease caused by vaccine serotype 9V in previously immunized adultsMeagan Deviaene, Alyssa R Golden, Terence Wuerz, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 23, 2026
Meagan Deviaene, Alyssa R Golden, Terence Wuerz, et al.
Epidemiology and Infection|December 23, 2024
Group A streptococcal infections in Alberta, Canada 2018-2023Gregory J Tyrrell, Matthew Croxen, Emily McCullough, et al.
JAMA Network Open|April 9, 2026
Invasive Pneumococcal Disease Epidemiology and Conjugate Vaccines in Canada, 2000-2019Bernice Ramos, Nirma Khatri Vadlamudi, Alyssa R Golden, et al.
Diagnostic Microbiology and Infectious Disease|February 22, 2020
In Vitro Activity of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacilli Isolated from Patients in Canadian Intensive Care UnitsAlyssa R Golden, Heather J Adam, Melanie Baxter, et al.
The Journal of Antimicrobial Chemotherapy|August 28, 2025
Comparison of antimicrobial resistance and serotype patterns in Streptococcus pneumoniae from blood cultures and respiratory specimens in Canadian hospitals from the CANWARD study (2007-23)Heather J Adam, Alyssa R Golden, Irene Martin, et al.
The Journal of Antimicrobial Chemotherapy|August 2, 2024
Phenotypic and molecular characterization of Streptococcus pneumoniae serotype 3 isolates from blood and respiratory samples in Canada: CANWARD 2007-21John J Schellenberg, Heather J Adam, Melanie R Baxter, et al.
Vaccine|September 27, 2023
Clonal diversity of Streptococcus pneumoniae serotype 19A collected from children < 5 years old in Québec, Canada, 2016-2021Alyssa R Golden, Brigitte Lefebvre, Geneviève Deceuninck, et al.
Diagnostic Microbiology and Infectious Disease|June 30, 2021
Invasive pneumococcal disease caused by serotypes 22F and 33F in Canada: the SAVE study 2011-2018Alyssa R Golden, Thomas Fear, Melanie Baxter, et al.
Pageof 5